NCT03695926View on ClinicalTrials.gov

Assessment of [18F]MNI-1054 as a Marker for LSD1

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

August 9, 2018

Primary Completion Date

May 2, 2019

Study Completion Date

May 2, 2019

Conditions
Healthy Volunteers (HV)
Interventions
DRUG

[18F]MNI-1054

Healthy volunteers recruited for the study will undergo a \[18F\]MNI-1054 PET scan.

Trial Locations (1)

06510

Invicro, New Haven

Sponsors

Lead Sponsor

Invicro
All Listed Sponsors
lead

Invicro

OTHER